PDEX
Pro-Dex, Inc. NASDAQ$48.36
Mkt Cap $162.5M
52w Low $23.47
56.1% of range
52w High $67.87
50d MA $48.19
200d MA $40.99
P/E (TTM)
17.7x
EV/EBITDA
11.3x
P/B
4.3x
Debt/Equity
0.5x
ROE
21.9%
P/FCF
-49.0x
RSI (14)
—
ATR (14)
—
Beta
-0.11
50d MA
$48.19
200d MA
$40.99
Avg Volume
25.7K
About
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consult…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 0.62 | 1.20 | +93.5% | 50.14 | -2.1% | -3.6% | — | — | — | — | — | — |
| Jan 29, 2026 | AMC | 0.59 | 0.66 | +11.9% | 39.41 | +1.2% | -0.5% | +1.6% | +1.6% | -0.3% | -2.4% | +17.1% | — |
| Oct 30, 2025 | AMC | 0.50 | 0.62 | +24.0% | 30.63 | +5.9% | +18.3% | +17.2% | +10.2% | +5.6% | +6.4% | +22.3% | — |
| Sep 4, 2025 | AMC | 0.47 | 0.36 | -23.4% | 45.74 | -5.2% | -16.5% | -22.2% | -20.4% | -22.0% | -23.1% | -26.0% | — |
| May 1, 2025 | AMC | 0.47 | 0.98 | +108.5% | 67.30 | -8.1% | -31.9% | -33.2% | -33.4% | -36.5% | -35.5% | -41.7% | — |
| Jan 30, 2025 | AMC | 0.38 | 0.61 | +60.5% | 42.95 | +0.3% | -11.6% | -17.8% | -20.0% | -24.4% | -20.0% | -16.0% | — |
| Oct 31, 2024 | AMC | 0.29 | 0.75 | +158.6% | 31.02 | +36.2% | +19.1% | +31.0% | +32.8% | +38.8% | +32.5% | +58.0% | — |
| Sep 5, 2024 | AMC | 0.35 | 0.46 | +31.4% | 22.26 | +1.1% | +4.6% | +19.0% | +21.5% | +15.5% | +17.3% | +25.8% | — |
| May 2, 2024 | AMC | 0.35 | 0.19 | -45.7% | 18.22 | +0.7% | +0.2% | -2.4% | -1.8% | +2.6% | +1.3% | +7.2% | — |
| Feb 8, 2024 | AMC | 0.35 | 0.14 | -60.0% | 21.11 | -3.8% | -11.9% | -15.6% | -16.2% | -14.8% | -13.1% | -17.6% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 | Ascendiant Capital | Maintains | Buy → Buy | — | $46.24 | $47.62 | +3.0% | -4.6% | -10.7% | -12.7% | -13.4% | -15.1% |
| Feb 22 | Ascendiant Capital | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Nov 11 | Ascendiant Capital | Maintains | Buy → Buy | — | $42.68 | $44.65 | +4.6% | +10.9% | +16.1% | +10.0% | +12.0% | +8.0% |
| Sep 9 | Ascendiant Capital | Maintains | Buy → Buy | — | $23.28 | $23.51 | +1.0% | +13.8% | +16.2% | +10.4% | +12.1% | +14.6% |
| Jan 4 | Ascendiant Capital | Maintains | Buy → Buy | — | $5.00 | $5.10 | +2.0% | +3.0% | +3.0% | +7.0% | +8.0% | +7.0% |
Recent Filings
8-K
Pro-Dex, Inc. -- 8-K Filing
Pro-Dex reports financial and operational results, with investors able to review detailed performance metrics through the company's latest 8-K disclosure.
Apr 30
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
PDEX's unexpected executive departure signals potential instability in leadership and strategy execution, risking investor confidence and operational continuity during a critical period.
Mar 27
8-K · 2.01
!!! Very High
Pro-Dex Inc New -- 8-K 2.01: Acquisition Completed
Pro-Dex completed its acquisition of Seller Parties, Inc., expanding its product portfolio and potentially enhancing operational capabilities through the strategic combination.
Feb 12
Data updated apr 26, 2026 7:05pm
· Source: massive.com